The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 10, 2001

Filed:

Nov. 03, 1997
Applicant:
Inventors:

Paul F. Torrence, Silver Spring, MD (US);

Robert Hugh Silverman, Beachwood, OH (US);

Nick Mario Cirino, Cleveland Heights, OH (US);

Guiying Li, Branford, CT (US);

Wei Xiao, North Potomac, MD (US);

Mark R. Player, Gaithersburg, MD (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 3/170 ; C12N 5/06 ; C07H 2/400 ; C07H 2/402 ;
U.S. Cl.
CPC ...
A61K 3/170 ; C12N 5/06 ; C07H 2/400 ; C07H 2/402 ;
Abstract

The present invention relates to methods of inhibiting infection by RNA viruses with complexes of an activator of RNase L and an oligonucleotide that is capable of binding to the genome, antigenome or mRNAs of a negative strand RNA virus to specifically cleave the genomic or antigenomic RNA strand of the virus. In accordance with the present invention, the methods and complexes of the invention may be applied to target any negative strand RNA virus. The invention in one embodiment relates to a covalently linked complex of an oligonucleotide that is capable of binding to the genomic or antigenomic template RNA strand of a negative strand RNA virus and/or binding to an mRNA of a viral protein (an “antisense oligonucleotide”) coupled to an activator of RNase L. In a preferred embodiment of the present invention, the oligonucleotide component of the complex is complementary to a region of the viral genomic RNA strand characterized by repeated or consensus sequences.


Find Patent Forward Citations

Loading…